These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4375789)

  • 61. [Sensitivity of strict anaerobic bacteria to metronidazole, cefoxitin, and clindamycin].
    Dubreuil L; Derriennic M; Reynaud A; Devos J; Romond C; Courtieu A
    Pathol Biol (Paris); 1985 Nov; 33(9):899-903. PubMed ID: 3909082
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The in vitro activity of the combination of daptomycin and metronidazole against Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus spp., and Bacteroides spp.
    Werner H; Nagy E; Heizmann WR
    J Chemother; 1989 Jul; 1(4 Suppl):207-8. PubMed ID: 16312371
    [No Abstract]   [Full Text] [Related]  

  • 63. The activity of four antimicrobial agents. Including three nitroimidazole compounds, against Bacteroides sp.
    Wise R; Andrews JM; Bedford KA
    Chemotherapy; 1977; 23(1):19-24. PubMed ID: 137803
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Susceptibility of Clostridium difficile to metronidazole, its bioactive metabolites and tinidazole.
    Bannatyne R; Jackowski J
    Eur J Clin Microbiol; 1987 Aug; 6(4):505-6. PubMed ID: 3665909
    [No Abstract]   [Full Text] [Related]  

  • 65. Antibacterial activity and pharmacokinetics of nitroimidazoles. A review.
    Bergan T
    Scand J Infect Dis Suppl; 1985; 46():64-71. PubMed ID: 3865352
    [TBL] [Abstract][Full Text] [Related]  

  • 66. BMY28142, cefbuperazone (T-1982), and Sch 34343. Antimicrobial activity against 94 anaerobes compared to seven other antimicrobial agents.
    Jones RN; Barry AL; Packer RR
    Diagn Microbiol Infect Dis; 1985 May; 3(3):263-8. PubMed ID: 3838925
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vitro activity of L-627 against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):757-60. PubMed ID: 1425740
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clostridium perfringens Type A Isolates of Animal Origin with Decreased Susceptibility to Metronidazole Show Extensive Genetic Diversity.
    Álvarez-Pérez S; Blanco JL; García ME
    Microb Drug Resist; 2017 Dec; 23(8):1053-1058. PubMed ID: 28346849
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A comparison of susceptibility results of the Bacteroides fragilis group and other anaerobes by traditional MIC results and statistical methods.
    Aldridge KE; Johnson WD
    J Antimicrob Chemother; 1997 Mar; 39(3):319-24. PubMed ID: 9096180
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro resistance of Clostridium perfringens type A to gentamicin sulfate, and reduced activity of the antibiotic under anaerobic atmospheric conditions.
    Traub WH; Raymond EA
    Chemotherapy; 1971; 16(3):162-5. PubMed ID: 4327182
    [No Abstract]   [Full Text] [Related]  

  • 71. Water Sources in a Zoological Park Harbor Genetically Diverse Strains of Clostridium Perfringens Type A with Decreased Susceptibility to Metronidazole.
    Álvarez-Pérez S; Blanco JL; Peláez T; Martínez-Nevado E; García ME
    Microb Ecol; 2016 Nov; 72(4):783-790. PubMed ID: 27115499
    [TBL] [Abstract][Full Text] [Related]  

  • 72. E-test: a new technique for antimicrobial susceptibility testing for periodontal microorganisms.
    Nachnani S; Scuteri A; Newman MG; Avanessian AB; Lomeli SL
    J Periodontol; 1992 Jul; 63(7):576-83. PubMed ID: 1324301
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Activity of metronidazole against experimental tetanus and gas gangrene.
    Freeman WA; McFadzean JA; Whelan JP
    J Appl Bacteriol; 1968 Dec; 31(4):443-7. PubMed ID: 4302783
    [No Abstract]   [Full Text] [Related]  

  • 74. Bactericidal activity of metronidazole, tinidazole and ornidazole against Bacteroides fragilis in vitro.
    Jokipii L; Jokipii AM
    J Antimicrob Chemother; 1977 Nov; 3(6):571-7. PubMed ID: 599119
    [No Abstract]   [Full Text] [Related]  

  • 75. Pharmacokinetics of tinidazole in the horse.
    Pyörälä S; Kotilainen T; Silvennoinen P; Hänninen U; Mero M; Kaartinen L
    J Vet Pharmacol Ther; 1990 Mar; 13(1):76-80. PubMed ID: 2319639
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Susceptibility of anaerobic bacteria to cefoxitin (author's transl)].
    Freydière AM; Gille Y; Marcel JP; Vincent P
    Sem Hop; 1980 Nov 18-25; 56(43-44):1793-5. PubMed ID: 6256880
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relationship between metronidazole metabolism and bactericidal activity.
    Chrystal EJ; Koch RL; McLafferty MA; Goldman P
    Antimicrob Agents Chemother; 1980 Oct; 18(4):566-73. PubMed ID: 6255861
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bioassay of metronidazole with either anaerobic or aerobic incubation.
    Ralph ED; Kirby WM
    J Infect Dis; 1975 Nov; 132(5):587-91. PubMed ID: 1185017
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nitroimidazoles: in vitro activity and efficacy in anaerobic infections.
    Tally FP; Goldin B; Sullivan NE
    Scand J Infect Dis Suppl; 1981; 26():46-53. PubMed ID: 6941456
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Metronidazole versus anaerobes. In vitro data and initial clinical observations.
    Tally FP; Sutter VL; Finegold SM
    Calif Med; 1972 Dec; 117(6):22-6. PubMed ID: 4635396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.